EFFICACY AND SAFETY STUDY OF THE ANTIHISTAMINE V0114CP 2.5MG IN THE TREATMENT OF SEASONAL ALLERGIC RHINITIS. RANDOMISED, DOUBLE-BLIND, THREE ARM PARALLEL GROUP STUDY INCLUDING PLACEBO AND ACTIVE CONTROL ARM (LEVOCETIRIZINE 5 MG) [ESTUDIO DE LA EFICACIA Y SEGURIDAD DEL ANTIHISTAMINICO V0114CP 2,5 MG EN EL TRATAMIENTO DE LA RINITIS ALERGICA ESTACIONAL. ESTUDIO ALEATORIZADO, DOBLE CIEGO, DE TRES RAMAS Y GRUPOS PARALELOS, QUE INCLUYE UNA RAMA DE PLACEBO Y OTRA DE CONTROL ACTIVO (LEVOCETIRIZINA 5 MG)].

Trial Profile

EFFICACY AND SAFETY STUDY OF THE ANTIHISTAMINE V0114CP 2.5MG IN THE TREATMENT OF SEASONAL ALLERGIC RHINITIS. RANDOMISED, DOUBLE-BLIND, THREE ARM PARALLEL GROUP STUDY INCLUDING PLACEBO AND ACTIVE CONTROL ARM (LEVOCETIRIZINE 5 MG) [ESTUDIO DE LA EFICACIA Y SEGURIDAD DEL ANTIHISTAMINICO V0114CP 2,5 MG EN EL TRATAMIENTO DE LA RINITIS ALERGICA ESTACIONAL. ESTUDIO ALEATORIZADO, DOBLE CIEGO, DE TRES RAMAS Y GRUPOS PARALELOS, QUE INCLUYE UNA RAMA DE PLACEBO Y OTRA DE CONTROL ACTIVO (LEVOCETIRIZINA 5 MG)].

Recruiting
Phase of Trial: Phase III

Latest Information Update: 04 Mar 2017

At a glance

  • Drugs Levocetirizine; Levomequitazine
  • Indications Seasonal allergic rhinitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Aug 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top